Video Experimental Relacionado
Updated: Feb 28, 2026
08:31
Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
Published on: December 1, 2020
5.6K
Binder2030: un conjunto de datos cuantitativo de proteoma de membrana que permite el descubrimiento de fármacos
Naoki Tarui1, Masaharu Nakayama1, Thuy Duong Nguyen1
1SEEDSUPPLY INC., 26-1, Muraoka-Higashi 2-Chome, Fujisawa, Kanagawa, 251-0012, Japan.
SLAS discovery : advancing life sciences R & D
|February 25, 2026
Resumen
Los investigadores crearon Binder2030, un gran conjunto de datos de ligandos de moléculas pequeñas y proteínas transmembrana. Este recurso proporciona mediciones estandarizadas para avanzar en el descubrimiento de fármacos para dianas como GPCR y canales iónicos.
Área de la Ciencia:
- Bioquímica
- Farmacología
- Biología Computacional
Sus antecedentes:
- Las proteínas de membrana son dianas terapéuticas cruciales pero carecen de datos cuantitativos integrales de unión a ligandos.
- Los conjuntos de datos existentes a menudo carecen de estandarización, lo que dificulta el análisis comparativo y los esfuerzos de descubrimiento de fármacos.
Objetivo del estudio:
- Establecer Binder2030, un conjunto de datos curado de interacciones ligando-proteína transmembrana de moléculas pequeñas.
- Proporcionar mediciones estandarizadas de la constante de disociación (Kd) para el análisis comparativo en diversas clases de dianas.
- Facilitar aplicaciones posteriores en el descubrimiento de fármacos y el modelado basado en estructuras.
Principales métodos:
- Espectrometría de masas de selección de afinidad (ASMS) utilizando la tecnología de selección de unión (BST) en fracciones de membrana.
- Mediciones estandarizadas de Kd, curación de identificadores químicos y anotaciones de dianas.
- Desarrollo de un subconjunto de superposición de PubChem con anotaciones de actividad para validación externa.
Principales resultados:
- El conjunto de datos Binder2030 incluye 3384 ligandos de moléculas pequeñas dirigidos a aproximadamente 400 proteínas transmembrana (GPCR, SLC, canales iónicos).
- Los valores estandarizados de Kd permiten el análisis de las distribuciones de afinidad y el espacio químico en las clases de dianas.
- Se demostró la integración exitosa con el modelado basado en estructuras, comparando las potencias predichas con las afinidades experimentales.
Conclusiones:
- Binder2030 expande significativamente los datos cuantitativos de unión a ligandos para proteínas de membrana.
- El conjunto de datos y las herramientas asociadas respaldan el análisis comparativo y aceleran el descubrimiento de nuevos terapéuticos.
- Facilita el diseño de fármacos basado en estructuras al vincular las afinidades experimentales con las predicciones computacionales.
Palabras clave:
descubrimiento de fármacos con IAEspectrometría de masas de selección de afinidadGPCRbase de datos de uniónproteínas de membranaMás Videos Relacionados
06:01Extracellular Protein Microarray Technology for High Throughput Detection of Low Affinity Receptor-Ligand Interactions
Published on: January 7, 2019
7.7K
15:04PeptiQuick, a One-Step Incorporation of Membrane Proteins into Biotinylated Peptidiscs for Streamlined Protein Binding Assays
Published on: November 2, 2019
11.4K
Videos de Conceptos Relacionados
02:04Protein-protein Interfaces
14.9K
Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a...
14.9K
02:40Ligand Binding Sites
15.4K
Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
15.4K
01:49Conserved Binding Sites
5.2K
Many proteins’ biological role depends on their interactions with their ligands, small molecules that bind to specific locations on the protein known as ligand-binding sites. Ligand-binding sites are often conserved among homologous proteins as these sites are critical for protein function.
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally...
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally...
5.2K
01:33Proteomics
10.0K
A proteome is the entire set of proteins that a cell type produces. We can study proteomes using the knowledge of genomes because genes code for mRNAs, and the mRNAs encode proteins. Although mRNA analysis is a step in the right direction, not all mRNAs are translated into proteins.
Proteomics is the study of proteomes' function. It involves the large-scale systematic study of the proteome to denote the protein complement expressed by a genome. Scientist Mark Wilkins coined the term...
Proteomics is the study of proteomes' function. It involves the large-scale systematic study of the proteome to denote the protein complement expressed by a genome. Scientist Mark Wilkins coined the term...
10.0K
02:18The Equilibrium Binding Constant and Binding Strength
15.4K
The equilibrium binding constant (Kb) quantifies the strength of a protein-ligand interaction. Kb can be calculated as follows when the reaction is at equilibrium:
15.4K
01:22Protein-Drug Binding: Determination Methods
734
Determining protein-drug binding can be achieved through indirect and direct methods, each providing valuable insights into the interaction between proteins and drugs.
Indirect methods involve isolating the bound drug from its free form in biological samples such as blood, serum, or plasma. These techniques aim to measure the percentage of drugs bound to proteins. Equilibrium dialysis is a commonly used method where the free drug concentration at equilibrium is measured by separating the bound...
Indirect methods involve isolating the bound drug from its free form in biological samples such as blood, serum, or plasma. These techniques aim to measure the percentage of drugs bound to proteins. Equilibrium dialysis is a commonly used method where the free drug concentration at equilibrium is measured by separating the bound...
734